Search

everythinglearnresearchcommunity

for

Search:↓

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The model and estimator can predict drug exposure in kidney transplant patients well.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

A woman with severe hair loss was successfully treated with the drug adalimumab.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Minoxidil, a blood pressure drug, can cause excessive hair growth, but this can be successfully treated with a hair removal agent called calcium thioglycolate.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

Finasteride's molecular and crystal structures help develop new drug formulations.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.